Advertisement

Topics

"Off-Label AVASTIN (BEVACIZUMAB) For Serosanguinous Maculopathy" Drugs and Medication Database

09:57 EST 18th February 2019 | BioPortfolio

Here are the most relevant "Off-Label AVASTIN (BEVACIZUMAB) For Serosanguinous Maculopathy" Drugs and Medications that we have found in our database.

More Information about "Off-Label AVASTIN (BEVACIZUMAB) For Serosanguinous Maculopathy" on BioPortfolio

We have published hundreds of Off-Label AVASTIN (BEVACIZUMAB) For Serosanguinous Maculopathy news stories on BioPortfolio along with dozens of Off-Label AVASTIN (BEVACIZUMAB) For Serosanguinous Maculopathy Clinical Trials and PubMed Articles about Off-Label AVASTIN (BEVACIZUMAB) For Serosanguinous Maculopathy for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Off-Label AVASTIN (BEVACIZUMAB) For Serosanguinous Maculopathy Companies in our database. You can also find out about relevant Off-Label AVASTIN (BEVACIZUMAB) For Serosanguinous Maculopathy Drugs and Medications on this site too.

Showing "Label AVASTIN BEVACIZUMAB Serosanguinous Maculopathy" Drugs and Medications, all 15

Relevant

Mvasi [amgen inc]

These highlights do not include all the information needed to use MVASI safely and effectively. See full prescribing information for MVASI .     MVASI (bevacizumab-awwb ) Solution for intravenous infusion Initial U.S. Approval: 2017 MVASI (bevacizumab-

Probably Relevant

Avastin [genentech, inc.]

These highlights do not include all the information needed to use AVASTIN safely and effectively. See full prescribing information for AVASTIN. AVASTIN (bevacizumab) injection, for intravenous useInitial U.S. Approval: 2004

Possibly Relevant

Tecentriq [genentech, inc.]

These highlights do not include all the information needed to use TECENTRIQ safely and effectively. See full prescribing information for TECENTRIQ. TECENTRIQ (atezolizumab) injection, for intravenous useInitial U.S. Approval: 2016

Cyramza [eli lilly and company]

These highlights do not include all the information needed to use CYRAMZA safely and effectively. See full prescribing information for CYRAMZA.CYRAMZA (ramucirumab) injection, for intravenous useInitial U.S. Approval: 2014

Lyophilized pegaspargase [baxalta us inc.]

LYOPHILIZED PEGASPARGASE

Oxygen, refrigerated liquid [procare inc]

Liquid Oxygen Drug Label

Oxygen [medox healthcare]

COMPRESSED OXYGEN LABEL AND LOT LABEL

Oxygen [medox healthcare]

LIQUID OXYGEN LABEL AND LOT LABEL

Oxygen [quality home medical, inc. ]

Oxygen

Oxygen [linweld, inc.]

Oxygen Label

Nitrogen [linweld, inc]

Nitrogen label

Oxygen [boggs gases div. boggs fire equipment]

Oxygen

Lysodren [e.r. squibb & sons, l.l.c.]

These highlights do not include all the information needed to use LYSODREN safely and effectively. See full prescribing information for LYSODREN.LYSODREN(mitotane) tablets, for oral useInitial U.S. Approval: 1970

Lysodren [laboratoire hra pharma]

These highlights do not include all the information needed to use LYSODREN safely and effectively. See full prescribing information for LYSODREN.LYSODREN(mitotane) tablets, for oral useInitial U.S. Approval: 1970

Oral-b minute-foam orang-a-tangy [oral-b laboratories]

Package.Label Principal Display Panel



Advertisement
Quick Search
Advertisement
Advertisement